rs10489346

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001146262.4(SYT14):​c.443-32359A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.05 in 151,740 control chromosomes in the GnomAD database, including 1,038 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.050 ( 1038 hom., cov: 32)

Consequence

SYT14
NM_001146262.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.489

Publications

1 publications found
Variant links:
Genes affected
SYT14 (HGNC:23143): (synaptotagmin 14) This gene is a member of the synaptotagmin gene family and encodes a protein similar to other family members that mediate membrane trafficking in synaptic transmission. The encoded protein is a calcium-independent synaptotagmin. Mutations in this gene are a cause of autosomal recessive spinocerebellar ataxia-11 (SCAR11), and a t(1;3) translocation of this gene has been associated with neurodevelopmental abnormalities. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 4. [provided by RefSeq, Dec 2011]
SYT14 Gene-Disease associations (from GenCC):
  • autosomal recessive spinocerebellar ataxia 11
    Inheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001146262.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.404 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001146262.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SYT14
NM_001146262.4
MANE Select
c.443-32359A>G
intron
N/ANP_001139734.1Q8NB59-6
SYT14
NM_001397544.1
c.1313-32359A>G
intron
N/ANP_001384473.1A0A8V8TN09
SYT14
NM_001397545.1
c.1313-32359A>G
intron
N/ANP_001384474.1A0A8V8TN09

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SYT14
ENST00000367019.6
TSL:1 MANE Select
c.443-32359A>G
intron
N/AENSP00000355986.1Q8NB59-6
SYT14
ENST00000472886.5
TSL:1
c.443-32359A>G
intron
N/AENSP00000418901.1Q8NB59-1
SYT14
ENST00000367015.5
TSL:1
c.329-32359A>G
intron
N/AENSP00000355982.1Q8NB59-3

Frequencies

GnomAD3 genomes
AF:
0.0500
AC:
7583
AN:
151622
Hom.:
1035
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00906
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.233
Gnomad ASJ
AF:
0.0205
Gnomad EAS
AF:
0.420
Gnomad SAS
AF:
0.0985
Gnomad FIN
AF:
0.0179
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00956
Gnomad OTH
AF:
0.0537
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0500
AC:
7592
AN:
151740
Hom.:
1038
Cov.:
32
AF XY:
0.0574
AC XY:
4259
AN XY:
74148
show subpopulations
African (AFR)
AF:
0.00904
AC:
375
AN:
41490
American (AMR)
AF:
0.234
AC:
3561
AN:
15190
Ashkenazi Jewish (ASJ)
AF:
0.0205
AC:
71
AN:
3460
East Asian (EAS)
AF:
0.419
AC:
2160
AN:
5156
South Asian (SAS)
AF:
0.0982
AC:
473
AN:
4816
European-Finnish (FIN)
AF:
0.0179
AC:
189
AN:
10564
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00956
AC:
648
AN:
67750
Other (OTH)
AF:
0.0536
AC:
113
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
279
558
837
1116
1395
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0259
Hom.:
41
Bravo
AF:
0.0693
Asia WGS
AF:
0.216
AC:
753
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
6.8
DANN
Benign
0.68
PhyloP100
-0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10489346;
hg19: chr1-210235308;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.